| answer text |
<p>The Healthcare Financial Management Association (HFMA) commissioned Bain and Company
to support vanguards as an extension to work previously commissioned from the company
as part of a programme called Future Focused Finance, an initiative sponsored by the
Department of Health and arm’s length bodies. This earlier work for the HFMA had focused
on the design of a value-based decision effectiveness tool, piloted in Mid-Cheshire
and Liverpool. The HFMA, in partnership with NHS England, commissioned the extension
to this work so that the tool could be used to support value-based decision-making
in the 2016-17 New Care Models programme.</p><p> </p><p>Alternatives were not sought
from competitors because the vanguard support built on the original Bain and Company
work for the HFMA.</p><p> </p><p>The value of the vanguard support contract is £650,000.
Value for money was obtained by negotiation, having been benchmarked with other commissions
made by the National Health Service to external health consultancies<em>. </em></p><p>
</p><p>As part of the contract, Bain and Company will be handing over its approach
to NHS England, so that NHS England can support other areas in implementing new care
models.</p><p><strong> </strong></p><p>Bain and Company has not been commissioned
to assess evidence to support transformation and potential for replication of new
care models in other areas. The company is commissioned to develop and implement a
framework that appropriately experienced NHS staff can use to assess such evidence.
Intellectual property rights in respect of the framework in the future are assigned
to HFMA under the terms of the contract. The NHS is entitled to use the framework
free of charge in perpetuity.</p><p><strong> </strong></p><p>Bain and Company is involved
in the development of the tool used to make the assessment, and in the implementation
of the process to use that tool. The company is specifically commissioned to help
vanguard sites to use the tool and to summarise the resulting value propositions to
facilitate decision-making by NHS England.</p><p> </p><p>No conflict of interest arises
as decisions concerning funding allocations for individual vanguards are made by NHS
England's Executive Team and Investment Committee and not Bain and Company.</p>
|
|
